Search

Liangli Li Yu

from Ellicott City, MD
Age ~59

Liangli Yu Phones & Addresses

  • 8705 Rochelle Dr, Ellicott City, MD 21043
  • 7749 Elmwood Rd, Fulton, MD 20759
  • Cambridge, MA
  • Somerville, MA
  • Edison, NJ
  • Bridgewater, NJ
  • Fort Collins, CO
  • North Brunswick, NJ
  • Franklin Park, NJ
  • Ames, IA

Publications

Us Patents

Use Of Cold-Pressed Edible Seed Oils, Flours, And/Or Blends Thereof As Anti-Inflammatory And Cox-2 Inhibitory Agents

View page
US Patent:
20070281044, Dec 6, 2007
Filed:
Jun 2, 2006
Appl. No.:
11/421926
Inventors:
Mark J. Mueller - Spooner WI, US
Liangli Yu - Ellicott City MD, US
International Classification:
A61K 36/23
A61K 36/889
A61K 36/45
A61K 36/73
A61K 36/87
US Classification:
424727, 424732, 424765, 424766, 424776
Abstract:
The present invention relates to an anti-inflammatory and COX-2 inhibitory composition that contains at least one of cold-pressed edible seed oils, flours and/or their derivatives having anti-inflammatory and COX-2 inhibitory activity as an active ingredient. The seed oils can be derived from at least one of red raspberry, black raspberry seed, black cumin seed, caneberry seed, raspberry seed, blackberry seed, marionberry seed, boysenberry seed, evergreen blackberry seed, coriander seed, sea buckthorn seed, palm fruit seed, cardomon seed, evening primrose seed, cranberry seed, mullein seed, parsley seed, carrot seed, blueberry seed, grape seed, chardonnay grape seed or merlot grape seed.

Sulfated Psyllium Derivative For Reducing The Risk Of Chronic Human Diseases And Method For Preparing The Same

View page
US Patent:
20110054207, Mar 3, 2011
Filed:
Jul 30, 2010
Appl. No.:
12/847747
Inventors:
LIANGLI YU - ELLICOTT CITY MD, US
WEI LIU - JIANGSU, CN
ZHOUHONG XIE - GREENBELT MD, US
QIN WANG - SAVOY IL, US
BOCE ZHANG - BEIJING, CN
Assignee:
UNIVERSITY OF MARYLAND - COLLEGE PARK MD
International Classification:
C07C 303/26
C07C 303/44
US Classification:
558 44
Abstract:
The invention is directed to a method for preparing sulfated psyllium derivatives for use to reduce the risk of chronic human diseases. The sulfation of psyllium was carried out with sulfur, trioxide, pyridine, dimethylformamide and chlorosulfonic acid in pyridine. Six total sulfated psyllium derivatives named SP1, SP2, SP3, SPR1, SPR2, and SPR3 were prepared and evaluated for their morphological and rheological properties, and bile acid-binding abilities. The invention offers a novel approach to obtaining sulfated psyllium derivatives for use in functional foods or supplemental and pharmaceutical products to increase health benefits.
Liangli Li Yu from Ellicott City, MD, age ~59 Get Report